Predict your next investment

HEALTHCARE | Medical Equipment & Supplies

See what CB Insights has to offer

Founded Year




Date of IPO


About Grand Pharmaceutical

Grand Pharmaceutical (HK: 00512) focuses on medicine production, medical devices and chemical raw materials.

Grand Pharmaceutical Headquarter Location

23rd Floor, Chengshi Plaza, Qiaokou Road No.160 Qiaokou District

Wuhan, Hubei,


Latest Grand Pharmaceutical News

FastWave Medical closes Series Pre-A funding round, acquired by China Grand Pharmaceutical

Aug 27, 2021

Medical Tubing and Extrusion Search this website August 27, 2021 FastWave Medical this week announced that it has closed its Series Pre-A financing round following its recent acquisition by China Grand Pharmaceutical and Healthcare Holdings. Minneapolis-based FastWave Medical, incubated by Big Sky Biomedical partners, earmarked the funds to advance research and development and to achieve key regulatory initiatives for its endovascular therapies to treat calcific artery disease. “Current interventional approaches for atherosclerosis can be anatomically limited, procedurally complex, or result in complications such as dissection, perforation, or embolization. FastWave’s proprietary technology aims to address these challenges with a safe, simple, and effective system that has the potential for becoming a new standard of care,” CEO Scott Nelson said in a news release . The acquisition by China Grand Pharmaceutical was previously announced on August 2 . China Grand Pharmaceutical will acquire 100% equity of FastWave Medical with up to a total of $72 million by phases and will invest up to total $8 million for supporting and jointly developing an intravascular shockwave calcification treatment system. Under the terms of the investment plus acquisition agreement, upon FastWave’s completion of key technical, clinical and regulatory milestone, it will be acquired subject to the satisfaction of closing conditions in the agreement. “We are extremely pleased to see FastWave close this round of financing. With the milestone-based acquisition agreement in place, it demonstrates strong support and confidence from our strategic partner,” JC Sun, founding partner of Big Sky Biomedical, said. “We were able to form the company and complete this transaction in less than 6 months. Not only am I very confident in the execution capabilities of our team, but we look forward to furthering our development efforts and demonstrating the next-level performance of FastWave’s platform to simplify and improve the safety and efficacy of endovascular arterial procedures for both physicians and patients.”

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Grand Pharmaceutical Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Grand Pharmaceutical Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.